{
 "companyname": "MAST THERAPEUTICS, INC.",
 "symbol": "MSTX",
 "description": "Pharmaceutical Preparations",
 "quarters": [
  {
   "cik": "0001160308",
   "companyname": "MAST THERAPEUTICS, INC.",
   "entityid": 91212,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "MSTX",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/12/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001564590-15-010584",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -127000,
   "changeincurrentliabilities": 1172000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -27000,
   "cashfromfinancingactivities": 14818000,
   "cashfrominvestingactivities": 4431000,
   "cashfromoperatingactivities": -8256000,
   "cfdepreciationamortization": 67000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": 4458000,
   "netchangeincash": 10993000,
   "totaladjustments": 1656000,
   "ebit": -9828000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 0,
   "incomebeforetaxes": -9912000,
   "interestexpense": -101000,
   "netincome": -9912000,
   "netincomeapplicabletocommon": -9912000,
   "researchdevelopmentexpense": 7330000,
   "totalrevenue": 0,
   "sellinggeneraladministrativeexpenses": 2460000,
   "commonstock": 164000,
   "deferredcharges": null,
   "cashandcashequivalents": 32207000,
   "cashcashequivalentsandshortterminvestments": 49913000,
   "goodwill": 3007000,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 8732000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": null,
   "propertyplantequipmentnet": 250000,
   "retainedearnings": -264810000,
   "totalassets": 63438000,
   "totalcurrentassets": 51449000,
   "totalcurrentliabilities": 13520000,
   "totalliabilities": 29899000,
   "totallongtermdebt": 12975000,
   "totalreceivablesnet": null,
   "totalshorttermdebt": 1537000,
   "totalstockholdersequity": 33539000,
   "treasurystock": null
  },
  {
   "cik": "0001160308",
   "companyname": "MAST THERAPEUTICS, INC.",
   "entityid": 91212,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "MSTX",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/12/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001564590-15-007108",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -562000,
   "changeincurrentliabilities": 1631000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -21000,
   "cashfromfinancingactivities": 2034000,
   "cashfrominvestingactivities": -221000,
   "cashfromoperatingactivities": -8533000,
   "cfdepreciationamortization": 37000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": -200000,
   "netchangeincash": -6720000,
   "totaladjustments": 1618000,
   "ebit": -10181000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 0,
   "incomebeforetaxes": -10151000,
   "interestexpense": -1000,
   "netincome": -10151000,
   "netincomeapplicabletocommon": -10151000,
   "researchdevelopmentexpense": 7734000,
   "totalrevenue": 0,
   "sellinggeneraladministrativeexpenses": 2410000,
   "commonstock": 164000,
   "deferredcharges": null,
   "cashandcashequivalents": 21214000,
   "cashcashequivalentsandshortterminvestments": 43379000,
   "goodwill": 3007000,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 8774000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": null,
   "propertyplantequipmentnet": 230000,
   "retainedearnings": -254898000,
   "totalassets": 56764000,
   "totalcurrentassets": 44753000,
   "totalcurrentliabilities": 10800000,
   "totalliabilities": 14229000,
   "totallongtermdebt": 25000,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 42535000,
   "treasurystock": null
  },
  {
   "cik": "0001160308",
   "companyname": "MAST THERAPEUTICS, INC.",
   "entityid": 91212,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "MSTX",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/11/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001564590-15-003918",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 438000,
   "changeincurrentliabilities": 733000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -70000,
   "cashfromfinancingactivities": -6000,
   "cashfrominvestingactivities": -519000,
   "cashfromoperatingactivities": -7349000,
   "cfdepreciationamortization": 30000,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": -449000,
   "netchangeincash": -7874000,
   "totaladjustments": 2267000,
   "ebit": -9650000,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 0,
   "incomebeforetaxes": -9616000,
   "interestexpense": 0,
   "netincome": -9616000,
   "netincomeapplicabletocommon": -9616000,
   "researchdevelopmentexpense": 6042000,
   "totalrevenue": 0,
   "sellinggeneraladministrativeexpenses": 3578000,
   "commonstock": 159000,
   "deferredcharges": null,
   "cashandcashequivalents": 27934000,
   "cashcashequivalentsandshortterminvestments": 49887000,
   "goodwill": 3007000,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 8903000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": null,
   "propertyplantequipmentnet": 248000,
   "retainedearnings": -244747000,
   "totalassets": 62720000,
   "totalcurrentassets": 50562000,
   "totalcurrentliabilities": 9181000,
   "totalliabilities": 12612000,
   "totallongtermdebt": 27000,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 50108000,
   "treasurystock": null
  }
 ]
}